Lixte Biotechnology
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -1,574 | -984 | -1,009 | -4 |
EBIT | -609 | -983 | -1,009 | -971 |
Net Income | -617 | -986 | -1,010 | -971 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -598 | -957 | -819 | -789 |
Cash | 1,038 | 1,637 | 2,595 | 3,414 |
Basic Shares | 2,249 | 2,249 | 2,249 | 2,249 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -3,572 | 3 | -1 | -7 |
EBIT | -3,602 | -5,087 | -6,312 | -6,728 |
Net Income | -3,585 | -5,087 | -6,304 | -6,735 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -3,164 | -4,293 | -4,611 | -4,142 |
Cash | 1,038 | 4,203 | 5,353 | 4,823 |
Basic Shares | 2,249 | 1,915 | 158 | 1,347 |
